Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06608134
EARLY_PHASE1

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis

Sponsor: R3 Medical Research

View on ClinicalTrials.gov

Summary

This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.

Official title: Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for

Key Details

Gender

All

Age Range

30 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2024-10-01

Completion Date

2029-10-01

Last Updated

2024-09-23

Healthy Volunteers

No

Interventions

BIOLOGICAL

Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection

Direct injection of biologic into the knee joint.

Locations (5)

R3 Anti Aging Scottsdale

Scottsdale, Arizona, United States

R3 Anti Aging Beverly Hills

Beverly Hills, California, United States

Optimal Medical Group

Fresno, California, United States

Scheer Medical Wellness

New York, New York, United States

Dr. Duc (Steve) Le, MD

Cleveland, Texas, United States